BioCentury | May 30, 2016
Company News

Astellas, Thunderbolt deal

...lupus erythematosus (SLE). The terms are not disclosed. Thunderbolt is the first company launched by Vitesse Biologics LLC...
BioCentury | May 26, 2016
Company News

Vitesse launches first newco Thunderbolt

Vitesse Biologics LLC (South San Francisco, Calif.) launched virtual newco Thunderbolt Pharma Inc. (South San Francisco, Calif.), which will house a preclinical dual antagonist program targeting BLyS (BAFF) and tumor necrosis factor (TNF) ligand superfamily...
BioCentury | Jul 13, 2015
Strategy

Baxalta's blueprint

...gained from SuppreMol. Baxalta also has an exclusive option to acquire each program developed by Vitesse Biologics LLC...
...and Drug Administration (FDA) , Silver Spring, Md. Velocity Pharmaceutical Development LLC, San Francisco, Calif. Vitesse Biologics LLC...
BioCentury | Jun 8, 2015
Company News

Velocity Pharmaceutical Development, Vitesse Biologics, Baxter, Mayo Clinic deal

...Baxter’s Baxter Ventures arm, the Mayo Clinic and Velocity Pharmaceutical formed Vitesse Biologics, a newco that will...
...be housed in its own virtual company. Velocity Pharmaceutical Development LLC , San Francisco, Calif. Vitesse Biologics LLC...
BioCentury | Jun 2, 2015
Company News

Baxter, Velocity, Mayo Clinic create Vitesse

...NYSE:BAX), the Mayo Clinic (Rochester, Minn.) and Velocity Pharmaceutical Development (South San Francisco, Calif.) formed Vitesse Biologics LLC...
Items per page:
1 - 5 of 5
BioCentury | May 30, 2016
Company News

Astellas, Thunderbolt deal

...lupus erythematosus (SLE). The terms are not disclosed. Thunderbolt is the first company launched by Vitesse Biologics LLC...
BioCentury | May 26, 2016
Company News

Vitesse launches first newco Thunderbolt

Vitesse Biologics LLC (South San Francisco, Calif.) launched virtual newco Thunderbolt Pharma Inc. (South San Francisco, Calif.), which will house a preclinical dual antagonist program targeting BLyS (BAFF) and tumor necrosis factor (TNF) ligand superfamily...
BioCentury | Jul 13, 2015
Strategy

Baxalta's blueprint

...gained from SuppreMol. Baxalta also has an exclusive option to acquire each program developed by Vitesse Biologics LLC...
...and Drug Administration (FDA) , Silver Spring, Md. Velocity Pharmaceutical Development LLC, San Francisco, Calif. Vitesse Biologics LLC...
BioCentury | Jun 8, 2015
Company News

Velocity Pharmaceutical Development, Vitesse Biologics, Baxter, Mayo Clinic deal

...Baxter’s Baxter Ventures arm, the Mayo Clinic and Velocity Pharmaceutical formed Vitesse Biologics, a newco that will...
...be housed in its own virtual company. Velocity Pharmaceutical Development LLC , San Francisco, Calif. Vitesse Biologics LLC...
BioCentury | Jun 2, 2015
Company News

Baxter, Velocity, Mayo Clinic create Vitesse

...NYSE:BAX), the Mayo Clinic (Rochester, Minn.) and Velocity Pharmaceutical Development (South San Francisco, Calif.) formed Vitesse Biologics LLC...
Items per page:
1 - 5 of 5